This is Jack. Jack is coming to Melbourne in October.
Be like Jack.


Be Like Jack    Be Like Jack

Come to Melbourne, Australia October 10-11th, 2018 for the
5th Biennial Why Study Mammographic Density? Conference

Keynote Speaker: Professor Jack Cuzick

Jack Cuzick is a director of Wolfson Institute of Preventive Medicine in London and a head of its Centre for Cancer Prevention. He is John Snow Professor of Epidemiology at Queen Mary, University of London. He holds a PhD in Mathematics and has previously worked at Oxford University and Columbia University, New York.  His current interests are in cancer epidemiology and clinical trials, with special interest in prevention and screening. He has been awarded CBE in Jan 2017, he is a Fellow of the Royal Society, Academy of Medical Sciences and the Royal Statistical Society.

Be like Jack.  Register now.

This is Laura. Laura knows a lot about WISDOM and is coming to Melbourne in October.
Be wise like Laura.

Be Like JackBe Like Laura

Come to Melbourne, Australia October 10-11th, 2018 for the
5th Biennial Why Study Mammographic Density? Conference

Keynote Speaker: Laura Esserman

Laura is an internationally recognized breast surgeon, breast oncology specialist, and visionary in personalized medicine, is revolutionizing breast cancer screening and treatment throughout our nation today.

As a Professor of Surgery and Radiology at the University of California, San Francisco (UCSF) and the Director of the UCSF Carol Franc Buck Breast Care Center, Dr. Esserman’s breast cancer work spans a spectrum from basic science to public policy issues and the impact of both on the delivery of clinical care. She is a provocative thought leader calling attention to and finding solutions for over-diagnosis and over-treatment of breast cancer, especially of DCIS.

Dr. Esserman led the creation of the University of California-wide Athena Breast Health Network, a learning system designed to integrate clinical care and research as it follows 150,000 women from screening through treatment and outcomes.  As part of the network, she has spearheaded the development of the WISDOM study to learn how to improve breast cancer screening by testing and comparing the safety and efficacy of a personalized screening strategy informed by each woman’s breast cancer risk and preferences against the standard of annual screening.

Dr. Esserman is a passionate and persistent advocate for her patients.  She is keenly aware that many of her patients don’t have 10 years to wait for the right treatment options. Her work is dedicated to accelerating the development of targeted, effective prevention and treatment options that can make a difference at the time when they are needed the most. Through these efforts, Dr. Esserman is helping to reshape the healthcare system, and changing it from a general population approach to a personalized and patient-centered care model.

Dr. Esserman was included as one of TIME Magazine’s 100 Most Influential People of 2016, and was the recipient of the 2016 Stanford Business School Ernest C. Arbuckle Award and the 2016 Personalized Medicine World Conference Pioneer and Luminary Award. The San Francisco Business Times honored her with the Most Influential Women in Business Awards for 2018, and she also received the 2018 Giant of Cancer Care® in Cancer Diagnostics award.

Be Like Laura. Register now.

YMD2018 is sponsored by:

Holologic logoVolpara Solutions logo

The Victorian Comprehensive Cancer Centre building from Elizabeth Street. Photography by Peter Bennetts.

The “Why Study Mammographic Density” meeting will be held at the Victorian Comprehensive Cancer Centre (VCCC), 305 Grattan Street, Melbourne, Victoria, Australia.

There are several hotels within a short walk:

The venue and hotels are within a 30-minute drive from Melbourne (Tullamarine) Airport.

YMD2018 is sponsored by:

Holologic logoVolpara Solutions logo

Call for Abstracts

Abstract submission for poster or presentation will open in March 2018 and close in August 2018.  Early notification of acceptance of Abstracts can be given if required to assist with travel and financial arrangements.


Abstract submission is now closed.

Melbourne CBD with Yarra River in foreground

YMD2018 is sponsored by:

Holologic logo

Volpara Solutions logo

Day 1: Oct 10th
Jump to Day 2

Morning session 1: 9-10:30

9:00-9:15: Welcome: Why mammographic density?
    John Hopper
9:15-9:30: What are the measurement issues?
    Jennifer Stone
9:30-9:50: What is BreastScreen’s perspective?
    Gail Ward
9:50-10:10: What is the Patient’s perspective?
    Michael Shepherd
10:10-10:20: What is the role of GPs?
    Jenny Walker
10:20-10:30 Discussion

Morning tea break 10:30-11am

Morning session 2: 11-12

11:00-11:20 What is happening in the US?
    Monica Saini
11:20-11:40 What are the Ethical and Legal Considerations?
    Wendy Ingman
11:40-12:00 What do BreastScreen participants know and do?
    Jennifer Stone

Lunch: 12-12:30

12:30-1:30: VCCC Breast Tumour Grand Rounds: Preventive therapy for breast cancer
    Jack Cuzick

Afternoon session 1: 1:30-3:30

1:30-1:50 What are the Health Economic implications of mammographic density in tailored screening?
    Carolyn Nickson
1:50-2:10 What are the implications of Family History?
    John Hopper
2:10-2:30 What is the underlying Biology?
    Kara Britt
2:30-3:00 Questions and Discussion

Afternoon tea break 3:00-3:30pm

Afternoon session 2: 3:30-5:00

3:30-3:50 What is the Radiologist’s perspective?
    Mary Rickard
3.50-4.10 What is the Clinician’s perspective?
    Christobel Saunders
4:10-4:20 What is BCNA’s (Breast Cancer Network Australia) Perspective?
    Daniele Spence
4:20-4:30 What is the VCCC’s (Victorian Comprehensive Cancer Centre) project on tailored screening?
    Bruce Mann
4:30-4:40 Who are the other stakeholders?
    Rik Thompson
4.40-5.00 Discussion

Conference dinner – Parkville precinct 6:30pm for 7pm start

Day 2: Oct 11th
Jump to Day 1

Morning session 1: 9-10:30: The Measurement of Breast Density

9:00-9:20 (+5min Questions) Optical Breast Spectroscopy (OBS) to identify women with elevated Mammographic Density and monitor its change in real time
    Lothar Lilge
9:25-9:35 (+5min Questions) Novel methods for measuring breast density in younger women: TiBS and DXA
    Dilukshi Perera
9:40-10:00 (+5min Questions) Effect of double-reading versus single-reading on the association between mammographic sensitivity and volumetric breast density
    Ariane Chan
10:05-10:25 (+5min Questions) Breast density in 35,000 BreastScreen mammograms: an overview of risk assessment and cancer outcomes using the AutoDensity automated measurement tool.
    Carolyn Nickson

Morning tea break 10:30-11am

Morning session 2: 11-12:00: The Biology of Breast Density

11:00-11:15 (+5min Questions) Modulation of Syndecan-1 in human breast tissue explants: Role of estrogen signalling involving heparanase.
    Xuan Huang
11:20-11:35 (+5min Questions) Associations between epithelial nuclear density (END), lobular involution (LI) and mammographic density (MD) among women undergoing diagnostic image-guided breast biopsy
    Maeve Mullooly
11:40-11:55 (+5min Questions) Correlation of microCT with single-sided NMR T1 values as a measure of mammographic density
    Honour Hugo

Lunch: 12-12:30

12:30-1:30 Plenary Talk: Title to be confirmed
    Laura Esserman

Afternoon session 1: 1:30-3:30: Mammographic Density and Breast Cancer Risk

1:30-1:50 (+5min Questions) Association between mammographic breast density and breast cancer risk following a benign breast biopsy
    Gretchen Gierach
1:55-2:05 (+5min Questions) The distribution and determinants of mammographic density in Western Australian Aboriginal women and its association with breast cancer risk
    Jennifer Stone
2:10-2:30 (+5min Questions) Risk of Interval Breast Cancer by Breast Density, Family History, and Breast Tissue Ageing
    Kevin Nguyen
2:35-2:55 (+5min Questions) Longitudinal modelling of mammographic density for accurate breast cancer risk estimation
    Emma C. Atakpa

3:00-3:30 Afternoon tea

Afternoon session 2: 3:30-5:00: You don’t want to miss…

3:30-3:45 (+5min Questions) Genome-wide association analysis of mammographic density in Malaysian women
    Shivaani Mariapun
3:50-4:05 (+5min Questions) Genetic profiles of breast cancers that arise in women with high or low MD
    Ian Campbell

4:10-4:25 (+5min Questions) Impact of rapid weight loss on mammographic density
    Ellie Darcey
4:30-4:45 (+5min Questions) How does breast density notification make women feel?
    Evenda Dench
4:50-5:00pm Meeting close and final comments

YMD2018 is sponsored by:

Holologic logoVolpara Solutions logo